Abstract
Triple negative breast cancers (TNBC) are a subtype of breast cancer characterized by negative expressions of estrogen receptor, progesterone receptor, and Her2/neu. Compared with other breast cancers, TNBC displays distinct clinic pathological features and prognosis, attracting much attention from oncology researchers. This review highlights the recent advances in the clinical characterization and treatment of TNBC. Key words: Breast neoplasms; Therapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have